imipramine has been researched along with desvenlafaxine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andree, T; Bicksler, J; Butch, J; Fletcher, H; Husbands, GE; James, MN; Moyer, JA; Muth, EA; Stack, G; Yardley, JP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for imipramine and desvenlafaxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for imipramine and desvenlafaxine
| Article | Year |
|---|---|
2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Binding, Competitive; Biological Assay; Biological Transport; Brain; Chemical Phenomena; Chemistry, Physical; Crystallography; Hypothermia; Imipramine; In Vitro Techniques; Models, Molecular; Neurotransmitter Agents; Norepinephrine; Phenethylamines; Rats; Receptors, Adrenergic, beta; Receptors, Serotonin; Reserpine; Serotonin; Structure-Activity Relationship; X-Ray Diffraction | 1990 |